Skip to main content
. 2017 Aug 30;1(10):1235–1246. doi: 10.1210/js.2017-00289

Figure 1.

Figure 1.

Mean ± SEM changes in (upper panels) plasma and (lower panels) CSF leptin levels after placebo or NTX treatment in lean and OW/OB subjects. (right-side panels) The percent changes in plasma and CSF leptin levels after NTX treatment vs placebo were significantly different in the lean vs the OW/OB groups. *P < 0.05; **P < 0.01.